# Feasibility of Adaptive Radiation Therapy for Human-papilloma Virus-positive Oropharyngeal Cancer Patients on MRIdian Linac

> **NCT05849142** · NA · WITHDRAWN · sponsor: **University of Miami**

## Conditions studied

- Oropharynx Cancer

## Interventions

- **DEVICE:** MRIdian Linac

## Key facts

- **NCT ID:** NCT05849142
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-12-01
- **Primary completion:** 2024-12-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** MRI Linac contract was not renewed at our institution after Viewray went bankrupt. Therefore we cannot do adaptive treatments on this machine. No patients were enrolled.
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05849142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05849142, "Feasibility of Adaptive Radiation Therapy for Human-papilloma Virus-positive Oropharyngeal Cancer Patients on MRIdian Linac". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT05849142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*